1. Home

Join us in the SSO HUB!

The SSO HUB is designed to provide an inviting environment that fosters a sense of community and encourages dialogue and debate. The “HUB” is organized into disease site zones with a center stage theater and mini theaters within each zone.

The SSO HUB Theater presents SSO education that is an extension of topics covered in plenary and parallel sessions. Developed by the Scientific Program Committee, content is in the form of Case Challenges, Clinical Trials Spotlights and the Great Debates. Industry education also takes place at the HUB Theater, including Industry Spotlights and Forums. Review the full to schedule to see HUB sessions.

SSO HUB Hours:

Thursday, March 10- 9:00 a.m.-7:00 p.m.
Friday, March 11- 9:00 a.m.-5:00 p.m.

Don’t forget to pack your cellphone and Earbuds, AirPods or Headphones to participate in the HUB Theater Sessions.

Below is a listing of SSO Theater presentations. Check the full program schedule for more information as well as information on HUB Zone educational sessions.

SSO HUB Theater Schedule

Colorectal: March 10, 9:00 – 9:30 am
Nuts and Bolts of Watch and Wait/Nonoperative Management for Rectal Cancer
Watch and wait has gained popularity especially for patients with low rectal cancers that require abdominoperineal resection or colonal anastomosis. However, many questions remain including the optimal neoadjuvant regimen, timing of evaluation of response, and long-term surveillance schedules. The surgical oncologist needs to be familiar the different neoadjuvant regimens to treat rectal cancer when considering watch and wait, how to deal with near complete responses and have long-term surveillance strategies.

HPB: March 10, 12:45 – 1:15 pm
How Can Molecular Analysis Resolve Dilemmas in IPMN Management?

Breast: March 10, 3:00 – 3:30 pm
Beyond Wires: Novel Localization Methods for Breast and Axillary Lesions
Participants will be able to: 1. review localization devices and techniques for breast lesions, 2. discuss use of localization devices for axillary and non-breast lesions, and 3. discuss limitations and challenges of various localization systems.

Upper GI: March 11, 9:30 – 10:00 am
Management of Limited Peritoneal Metastasis from Gastric Cancer After Conversion of Positive Washing to Negative
An overview of updates in evidence and practice management to assist the surgeon in managing limited peritoneal metastasis from gastric cancer. 

Cross Discipline/Pan Tumor: March 11, 10:45 – 11:30 am
How to Leverage Social Media to Enhance Your Practice and Career

Immuno-Oncology: March 11, 1:15 – 1:45pm
Tumor Board: Neoadjuvant Immunotherapy and TVEC for Melanoma

Melanoma: March 11, 4:00 – 4:30 pm
Skin Cancer Tumor Board: (2 cases – Melanoma, Merkel Cell Carcinoma)

Sarcoma: March 11, 4:30 – 5:00 pm
Defining Resectability in Sarcoma: In the Eyes of the Beholder